Home › Psoriatic Arthritis › New Jersey
Psoriatic Arthritis clinical trials in New Jersey
3 studies for Psoriatic Arthritis are looking for participants at sites in New Jersey.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Hackensack University Medical Center, Hackensack
- Goryeb Children's Hospital, Morristown
- Robert Wood Johnson Medical School, New Brunswick
- and 1 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 140, West Long Branch
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT07290036From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.